Enomoto S., Nakatsuka S., Kuwayama T., Kawatsu K., Yokogawa M., Osawa M. NMR 1H, 13C, 15N backbone resonance assignments of 14-3-3ζ binding region of human FOXO3a (residues 1-284). Biomolecular NMR Assignments. 2024. 18. 2. 275-283
Martina Stillinovic, Mayuresh Anant Sarangdhar, Nicola Andina, Aubry Tardivel, Frédéric Greub, Giuseppe Bombaci, Camille Ansermet, Marco Zatti, Dipanjali Saha, Jieyu Xiong, et al. Ribonuclease inhibitor and angiogenin system regulates cell type-specific global translation. Science advances. 2024. 10. 22. eadl0320
Shimizu Y, Yonezawa T, Bao Y, Sakamoto J, Yokogawa M, Furuya T, Osawa M, Ikeda K. Applying deep learning to iterative screening of medium-sized molecules for protein-protein interaction-targeted drug discovery. Chemical Communications. 2023. 59. 44. 6722-6725
Miura M., Sakaue F., Matsuno H., Morita K., Yoshida A., Hara R.I., Nishimura R., Nishida Y., Yokogawa M., Osawa M., et al. TDP-43 N-terminal domain dimerisation or spatial separation by RNA binding decreases its propensity to aggregate. FEBS Letters. 2023. 597. 12. 1667-1676
Sagae T., Yokogawa M., Sawazaki R., Ishii Y., Hosoda N., Hoshino SI, Imai S., Shimada I., Osawa M. Paip2A inhibits translation by competitively binding to the RNA recognition motifs of PABPC1 and promoting its dissociation from the poly(A) tail. The Journal of biological chemistry. 2022. 298. 5. 101844-101844
Development of novel anti-HBV drugs based on AI technology using bile acid derivatives to inhibit HBV and NTCP binding
(International HBV Meeting 2024 2024)